3,4-Dichloro-N-(1-Methylbutyl)benza-Mide
3,4-Dichloro-N-(1-Methylbutyl)benza-Mide Basic information
- Product Name:
- 3,4-Dichloro-N-(1-Methylbutyl)benza-Mide
- Synonyms:
-
- 3,4-Dichloro-N-(1-Methylbutyl)benza-Mide
- NSC 405020
- 3,4-DICHLORO-N-(PENTAN-2-YL)BENZAMIDE
- 3,4-Dichloro-N-(1-methylbutyl)-benzamide NSC405020
- NSC 405020 3,4-Dichloro-N-(1-methylbutyl)-benzamide
- NSC 405020, >=98%
- NSC 405020, 7497-07-6
- NSC 405020;NSC-405020
- CAS:
- 7497-07-6
- MF:
- C12H15Cl2NO
- MW:
- 260.16
- EINECS:
- 804-136-9
- Product Categories:
-
- Inhibitors
- Mol File:
- 7497-07-6.mol
3,4-Dichloro-N-(1-Methylbutyl)benza-Mide Chemical Properties
- Boiling point:
- 353.7±32.0 °C(Predicted)
- Density
- 1.182±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- solubility
- Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 25 mg/ml).
- form
- powder
- pka
- 13.38±0.46(Predicted)
- color
- white to beige
- Stability:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
3,4-Dichloro-N-(1-Methylbutyl)benza-Mide Usage And Synthesis
Description
NSC-405020 (7497-07-6) is a membrane type-1 matrix metalloproteinase (MMP14 or MT1-MMP) inhibitor that prevents homodimerization and inhibits MMP14’s protumorigenic activity?in vivo. (IC50?> 100 μM). Inhibition is via interaction with the hemopexin domain (PEX) of MMP14. NSC-405020 does not interfere with the catalytic activity of MT1-MMP or MMP-2.? Suppresses bone erosion in a c-Fos-deficient mouse model.2?Decreases arsenic-mediated invasion of human squamous cell carcinoma HSC5 cells.3
Uses
NSC 405020 is a novel, selective, and noncatalytic membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor that directly interacts with the homopexin (PEX) domain of MT1-MMP.
storage
Store at RT
References
1) Remacle?et al.?(2012),?Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth;? Cancer Res.,?72?2339 2) Kittaka?et al.?(2018)?Cherubism Mice Also Deficient in c-Fos Exhibit Inflammatory Bone Destruction Executed by Macrophages That Express MMP14 Despite the Absence of TRAP+ Osteoclasts?; J. Bone Miner. Res.,?33?167 3) Thang?et al.?(2014)?Bidirectional functions of arsenic as a carcinogen and an anti-cancer agent in human squamous cell carcinoma; PLoS One,?9(5)?e96945
3,4-Dichloro-N-(1-Methylbutyl)benza-MideSupplier
- Tel
- sales@boylechem.com
- Tel
- +86 (531) 88811783
- sales@trio-pharmatech.com (International market)
- Tel
- 0411-62910999 13889544652
- meilunui@163.com
- Tel
- 021-58950125
- info@chemexpress.com
- Tel
- 400-400-6206333 18521732826
- market@aladdin-e.com
3,4-Dichloro-N-(1-Methylbutyl)benza-Mide(7497-07-6)Related Product Information
- Roxadustat
- 4-Chloro-N,N-diethylbenzaMide, 97%
- 4-Chloro-N,N-di-n-propylbenzaMide, 97%
- TIMTEC-BB SBB006342
- NSC781406
- 2,4-Thiazolidinedione,5-[(4-hydroxy-3-methoxyphenyl)methylene]-
- 4-Chloro-N,N-diisopropylbenzamide
- Pifithrin-μ
- 2-Pyridinecarbothioamide, N-2-pyridinyl-
- 1,3-Bis(4-aminophenyl)urea
- 5-(4-iodobenzylidene)rhodanine
- S3I-201
- NSC228155
- NSC632839hydrochloride
- NSC23005 Sodium
- HAMNO
- NSC 247030
- 5-(2-HYDROXY-BENZYLIDENE)-THIAZOLIDINE-2,4-DIONE